254 related articles for article (PubMed ID: 18519973)
1. Lymphatic involvement in lymphangioleiomyomatosis.
Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
[TBL] [Abstract][Full Text] [Related]
2. Involvement of lymphatics in lymphangioleiomyomatosis.
Glasgow CG; Taveira-DaSilva A; Pacheco-Rodriguez G; Steagall WK; Tsukada K; Cai X; El-Chemaly S; Moss J
Lymphat Res Biol; 2009 Dec; 7(4):221-8. PubMed ID: 20143921
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
[TBL] [Abstract][Full Text] [Related]
4. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
Glasgow CG; El-Chemaly S; Moss J
Eur Respir Rev; 2012 Sep; 21(125):196-206. PubMed ID: 22941884
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic manifestations of lymphangioleiomyomatosis.
Gupta R; Kitaichi M; Inoue Y; Kotloff R; McCormack FX
Lymphology; 2014 Sep; 47(3):106-17. PubMed ID: 25420303
[TBL] [Abstract][Full Text] [Related]
7. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
[TBL] [Abstract][Full Text] [Related]
9. Lymphangioleiomyomatosis: a disease involving the lymphatic system.
Seyama K; Kumasaka T; Kurihara M; Mitani K; Sato T
Lymphat Res Biol; 2010 Mar; 8(1):21-31. PubMed ID: 20235884
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
12. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Souma S; Kashiwagi S; Hebisawa A; Sato T; Kubo H; Gomi K; Shibuya K; Fukuchi Y; Suda K
Am J Surg Pathol; 2005 Oct; 29(10):1356-66. PubMed ID: 16160479
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.
Issaka RB; Oommen S; Gupta SK; Liu G; Myers JL; Ryu JH; Vlahakis NE
Am J Pathol; 2009 Oct; 175(4):1410-20. PubMed ID: 19717640
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
Nishino K; Yoshimatsu Y; Muramatsu T; Sekimoto Y; Mitani K; Kobayashi E; Okamoto S; Ebana H; Okada Y; Kurihara M; Suzuki K; Inazawa J; Takahashi K; Watabe T; Seyama K
Sci Rep; 2021 Apr; 11(1):8406. PubMed ID: 33863980
[TBL] [Abstract][Full Text] [Related]
16. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP
Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
Steagall WK; Pacheco-Rodriguez G; Glasgow CG; Ikeda Y; Lin JP; Zheng G; Moss J
Am J Pathol; 2013 Sep; 183(3):938-50. PubMed ID: 23867796
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
20. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
